Kaneka Ubiquinol has won Raw Material Supplier of the Year at the 2024 Complementary Medicines Australia (CMA) awards.
The designation recognises Kaneka Ubiquinol's advancement in the fields of complementary medicine and nutraceuticals.
CMA is a prominent industry body for the complementary medicines market, supporting suppliers, distributors, manufacturers and other professionals.
These awards are a testament to Kaneka's commitment to research and development, manufacturing and quality control when creating products for cardiovascular and cognitive health, as well as mitochondrial and healthy ageing support.
Head of Marketing and Sales Supplement Division APAC, Kaneka Corporation, Japan, Tsuyoshi Takakuwa, commented: “We are deeply honoured for Kaneka Ubiquinol to be named the recipient of the prestigious CMA Raw Material Supplier of the Year Award 2024,”
“The role Pharmacists play in recommending Ubiquinol in health protocols to their patients whether for energy, cognition or duo-prescribing with cholesterol management medications plays a key role in the success of our ingredient and we are deeply grateful,” he continued.
“Australia sets the highest benchmark in excellence in complementary medicines globally, and this award is one of the greatest industry accolades we could receive, not only for our teams but for our customers, Australia’s leading brandholders, and those in the rest of APAC, and their consumers, who vote with their pocket,” Takakuwa said.
“We extend our gratitude to Complementary Medicines Australia and the awards committee for this recognition, as well as to our partners and supporters. It is an honour to share this moment with other industry leaders who are also advancing health and innovation.” Kazuki Takita, Marketing and Sales, APAC concluded.